Total Funding
27
Total FundingGrant raised
Growth Score
pts
Heat Score
-9 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
196950
Twelve Bio is a developer of CRISPR-Cas12a diagnostic technology can detect and change any DNA sequence.
- Stefano Stella: Chief Technology Officer / Founder
- Gita Dittmar: Executive Chair(wo)manPast Role: ETHRIS, CEO
About the Company
Twelve Bio is a developer of CRISPR-Cas12a diagnostic technology can detect and change any DNA sequence. CRISPR-Cas12a is an RNA-protein molecule that allow us to identify and modify specific DNA sequences. The RNA works like a search engine that identifies the specific DNA sequence and the protein is the biological scissor that cuts it.
